Parcel Biosciences, Inc.
About
Parcel Biosciences is a seed-stage biotechnology startup founded in 2023, focused on developing next-generation RNA therapeutics. The company is creating a nanoparticle-free delivery system for mRNA medicines, aiming to overcome the technical limitations of current lipid nanoparticle technologies. This innovative approach is designed to enable targeted delivery of therapeutics to specific cell types, expanding the potential applications of mRNA beyond vaccines.
Company Values
The company's core innovation is its STAmP™ platform, a delivery system that protects mRNA from degradation without using nanoparticles. This method allows for precise, cell-specific targeting and is designed to be safer for systemic applications and higher doses compared to traditional delivery technologies.